Serial Number | 98294074 |
Word Mark | NEOGENOMICS |
Filing Date | Friday, December 1, 2023 |
Status | 645 - FINAL REFUSAL - MAILED |
Status Date | Monday, September 30, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Education services, namely, providing training and on-demand on-line training in the form of courses, seminars and workshops in the fields of pathology, medical testing, medical tests, diagnostic testing, oncology testing, human disease and human medical conditions; Education services, namely, providing non-downloadable webinars in the fields of pathology, medical testing, medical tests, diagnostic testing, oncology testing, human disease and human medical conditions; oncology reference laboratory services |
Description of Mark | The mark consists of two curved lines overlapping each other. To the right of the two curved lines overlapping each other is the bold capital letters "NEO". Directly beneath the bold capital letters "NEO" are smaller capital letters that spell "GENOMICS". |
Goods and Services | Medical tests kits primarily comprised of medical diagnostic reagents and assays for testing body fluids |
Goods and Services | Printed publications, namely, newsletters and abstracts in the fields of pathology, medical testing, medical tests, diagnostic testing, oncology testing, human disease and human medical conditions |
Indication of Colors claimed | Color is not claimed as a feature of the mark. |
Goods and Services | Medical diagnostic testing services in the field of human disease and human medical conditions; medical analysis services for diagnostics and testing purposes provided by medical laboratories; medical analysis services for diagnostics and testing purposes provided by oncology medical laboratories |
Goods and Services | Scientific testing and research services in the field of human disease and human medical conditions; providing medical research services in the field of human disease and human medical conditions; providing clinical scientific testing services and medical research and testing for medical research and medical diagnostic purposes in the field of human disease and human medical conditions; medical research laboratory services; oncology reference medical research laboratories; providing medical research information, interactive medical research information; and preparing and providing reports to others summarizing and analyzing results of scientific testing and research in the field of pathology, diagnostic testing, oncology testing |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, December 1, 2023 |
Primary Code | 005 |
First Use Anywhere Date | Friday, January 1, 2021 |
First Use In Commerce Date | Friday, January 1, 2021 |
International Class | 016 - Paper, cardboard and goods made from these materials, not included in other classes; printed matter; bookbinding material; photographs; stationery; adhesives for stationery or household purposes; artists' materials; paint brushes; typewriters and office requisites (except furniture); instructional and teaching material (except apparatus); plastic materials for packaging (not included in other classes); printers' type; printing blocks. |
US Class Codes | 002, 005, 022, 023, 029, 037, 038, 050 |
Class Status Code | 6 - Active |
Class Status Date | Friday, December 1, 2023 |
Primary Code | 016 |
First Use Anywhere Date | Friday, January 1, 2021 |
First Use In Commerce Date | Friday, January 1, 2021 |
International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
US Class Codes | 100, 101, 107 |
Class Status Code | 6 - Active |
Class Status Date | Friday, December 1, 2023 |
Primary Code | 041 |
First Use Anywhere Date | Friday, January 1, 2021 |
First Use In Commerce Date | Friday, January 1, 2021 |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, December 1, 2023 |
Primary Code | 042 |
First Use Anywhere Date | Friday, January 1, 2021 |
First Use In Commerce Date | Friday, January 1, 2021 |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, December 1, 2023 |
Primary Code | 044 |
First Use Anywhere Date | Friday, January 1, 2021 |
First Use In Commerce Date | Friday, January 1, 2021 |
Party Name | NeoGenomics Laboratories, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Fort Myers, FL 33912 |
Event Date | Event Description |
Friday, December 1, 2023 | NEW APPLICATION ENTERED |
Sunday, February 25, 2024 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Sunday, February 25, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Friday, May 31, 2024 | ASSIGNED TO EXAMINER |
Monday, June 3, 2024 | NON-FINAL ACTION E-MAILED |
Monday, June 3, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, June 3, 2024 | NON-FINAL ACTION WRITTEN |
Thursday, August 29, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, August 29, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, August 29, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, September 30, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
Monday, September 30, 2024 | FINAL REFUSAL WRITTEN |
Monday, September 30, 2024 | FINAL REFUSAL E-MAILED |